Sign In
Buy DOCS
$21.04
-0.470 (-2.19%)
At Close: Jun 03, 2026
Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks
08:20am, Tuesday, 19'th Nov 2024
Top-ranked stocks Amazon.com (AMZN), Maplebear Inc. (CART), Exelixis (EXEL) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases.
Surging Earnings Estimates Signal Upside for Doximity (DOCS) Stock
01:20pm, Friday, 15'th Nov 2024
Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Doximity Q2 Earnings: Positioning Is Paying Off
08:00am, Friday, 15'th Nov 2024
I rate Doximity a buy with a price target of $65, reflecting a 24% upside due to strong Q2 earnings and favorable industry trends. Doximity's Q2 earnings showed impressive revenue growth, margin expan
Dr. Martens upgraded to Neutral from Sell at Goldman Sachs
04:18pm, Wednesday, 13'th Nov 2024
Goldman Sachs analyst Louise Singlehurst upgraded Dr. Martens to Neutral from Sell with a price target of 64 GBp, down from 71 GBp. The firm sees emerging valuation support post the recent de-rating o
Why Doximity Stock Is Skyrocketing Today
02:06pm, Friday, 08'th Nov 2024
The market loved what it saw from Doximity's second-quarter earnings.
Why Doximity Stock is Set to Open at Highest Point in Over 2 Years Friday
08:45am, Friday, 08'th Nov 2024
Doximity (DOCS) shares jumped nearly 40% in premarket trading Friday after the medical tech company's earnings and outlook came in above what analysts expected.
Doximity Stock Soars 42% Toward Best Day Ever. It's Not the Only Record.
08:03am, Friday, 08'th Nov 2024
The online medical platform reported quarterly revenue of $136.8 million and earnings of 30 cents a share, beating analysts expectations.
Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript
10:07pm, Thursday, 07'th Nov 2024
Doximity, Inc. (NYSE:DOCS ) Q2 2025 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Perry Gold - Vice President of Investor Relations Jeff Tangney - Co-Founder and CEO Anna B
Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates
06:51pm, Thursday, 07'th Nov 2024
Doximity (DOCS) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.22 per share a year ago.
Morgan Stanley Upbeat On This Telehealth Stock; 80% Of Doctors Use It
12:20pm, Thursday, 31'st Oct 2024
This telehealth technology provider is holding above its 50-day moving average. The company reports its next earnings on Nov. 7.
Doximity (DOCS) Outperforms Broader Market: What You Need to Know
07:20pm, Tuesday, 29'th Oct 2024
Doximity (DOCS) closed at $41.88 in the latest trading session, marking a +1.11% move from the prior day.
Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:20pm, Wednesday, 23'rd Oct 2024
In the most recent trading session, Doximity (DOCS) closed at $41.42, indicating a -1.76% shift from the previous trading day.
Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024
04:01pm, Thursday, 17'th Oct 2024
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter
3 Medical Services Stocks to Buy to Navigate Industry Challenges
12:35pm, Thursday, 17'th Oct 2024
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, DOCS and HQY are set to gain the most.
Overlooked Stock: DOCS
04:50pm, Tuesday, 15'th Oct 2024
Doximity (DOCS) is trading near its 52-week high after getting an upgrade from Barclays. George Tsilis talks about why the "LinkedIn for physicians" can be gaining investor interest.
